Skip to content

The effect ofTranscutaneous electrical nerve stimulation onrestless legs syndrome

The effect ofTranscutaneous electrical nerve stimulation on the severity of restless legs syndrome in hemodialysis patients referred to the dialysis ward of Sabzevar Vasei Hospital and Imam Khomeini Hospital in Esfarayen

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220601055047N1
Enrollment
60
Registered
2022-09-03
Start date
2022-07-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severity of restless leg syndrome in hemodialysis patients. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group: In this study, after confirming restless leg syndrome, TENS electric current with a frequency of 100 Hz will be performed for the patients of the test group for 3 t

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Hemodialysis patients aged 18-75 years and older suffering from restless leg syndrome based on the self-report of the hemodialysis patient no history of neurological and mental illness except restless leg syndrome Absence of vascular diseases except restless leg syndrome absence of neuromuscular disorders, absence of crisis experience during the last 3 months

Exclusion criteria

Exclusion criteria: The patient's unwillingness to cooperate Antispasmodic use in the past two weeks Anticonvulsant use within the past two weeks Use of sedatives in the past two weeks Use of antidepressants in the past two weeks Use of herbal medicines during the last two weeks

Design outcomes

Primary

MeasureTime frame
Severity of restless legs syndrome. Timepoint: 3 shifts of 20 minutes. Method of measurement: Restless Leg Syndrome International Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazal Kalmishi

Sabzevar University of Medical Sciences

a.kalmish2020@gmail.com+98 58 3722 6852

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026